Grifols, S.A. - American Depositary Shares (GRFS) earnings
Quarterly and annual GRFS reports and results, each read against the price at its own news timestamp. Back to the GRFS overview →
1 measured GRFS earnings event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Grifols 2023 Annual Report on Form 20-F filed with the SEC | Press release | -0.55% | -0.32% |
Keep exploring
More GRFS: analyst actions → · SEC filings → · GRFS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Repligen Corporation (RGEN) | 301 | +0.15% | 55% |
| EIDOS THERAPEUTICS (EIDX) | 300 | +0.01% | 51% |
| Sangamo Therapeutics, Inc. (SGMO) | 300 | -0.55% | 38% |
| Merit Medical Systems, Inc. (MMSI) | 299 | -0.03% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.